Market Place
Sourcing Support
Wuxi Biologics Completes Chengdu Microbial Manufacturing Site
24 Apr 2026 //
PR NEWSWIRE BIO
WuXi Biologics Secures Korean MFDS GMP for Bispecific Antibodies
23 Apr 2026 //
PR NEWSWIRE
Hanchorbio, Wuxi Biologics Partner To Advance Fusion Protein
26 Jan 2026 //
PR NEWSWIRE BIO
Wuxi Biologics Launches Patrolab Digital Twin Platform
15 Jan 2026 //
INDPHARMAPOST
Wuxi Bio Attains Top "A" Ratings In Climate Change And Water
19 Dec 2025 //
PR NEWSWIRE
WuXi Biologics Signs Strategic MoU with Qatar Free Zones
02 Dec 2025 //
PR NEWSWIRE
WuXi Bio Receives MSCI AAA ESG Rating for Third Consecutive Year
09 Oct 2025 //
PR NEWSWIRE
WuXi Biologics Introduces TrueSite TI Cell Line Platform
25 Sep 2025 //
PR NEWSWIRE
WuXi Biologics` 3 Facilities in Turkey Obtain GMP Certification
17 Sep 2025 //
PR NEWSWIRE
WuXi Biologics Wins `CDMO of the Year` at IMAPAC Awards
11 Sep 2025 //
PR NEWSWIRE
WuXi Biologics Introduces Green CRDMO White Paper for Biologics
09 Sep 2025 //
PR NEWSWIRE
WuXi Biologics` Near-Term and Net-Zero Targets Approved by SBTi
28 Aug 2025 //
PR NEWSWIRE
WuXi Biologics Posts Strong 2025 Interim Results
19 Aug 2025 //
PR NEWSWIRE
EMA approves WuXi Biologics Ireland facility for biologic Mfg
18 Aug 2025 //
PR NEWSWIRE
WuXi Biologics Achieves Automated Continuous Drug Production
12 Aug 2025 //
PR NEWSWIRE
WuXi Biologics Launches WuXia293 for Hard Molecule Development
11 Aug 2025 //
PR NEWSWIRE
WuXi Biologics Launches Modular Drug Facility in Singapore Hub
30 Jul 2025 //
PR NEWSWIRE
WuXi Biologics Gets FDA PLI Nod for 5 Facilities
22 Jul 2025 //
PR NEWSWIRE
WuXi Biologic Receives ESG Rating from Morningstar Sustainalytics
16 Jul 2025 //
PR NEWSWIRE
WuXi Biologics Launches WuXiHigh 2.0 Biologics Platform
30 Jun 2025 //
PR NEWSWIRE
WuXi Biologics Releases 2024 Sustainability Report
29 Apr 2025 //
PR NEWSWIRE
WuXi Biologics Recognized by CDP for Climate Change Leadership
22 Apr 2025 //
PR NEWSWIRE
WuXi Biologics Completes First Commercial PPQ Campaign in Hangzhou
18 Apr 2025 //
PR NEWSWIRE
WuXi Biologics Wins CDMO Leadership Awards 8th Year
23 Mar 2025 //
PR NEWSWIRE
WuXi Biologics Again Passed GMP Inspection by Japan PMDA
27 Feb 2025 //
PR NEWSWIRE
WuXi Biologics Wins Platinum Medal from EcoVadis for 2nd Year
18 Feb 2025 //
PR NEWSWIRE
WuXi Biologics Named ESG Top-Rated Company by Morningstar
10 Feb 2025 //
PR NEWSWIRE
Candid steps up TCE deal momentum with $925M WuXi partnership
07 Jan 2025 //
BUSSINESSWIRE
WuXi Biologics to sell Irish vaccine site to Merck for $500M
07 Jan 2025 //
ENDPTS
China`s WuXi to sell Advanced Therapies unit amid US restrictions
26 Dec 2024 //
REUTERS
WuXi Hits Milestones with 16,000L PPQ and GMP Authorizations
05 Dec 2024 //
PR NEWSWIRE
WuXi Biologics Germany Expands with Prefilled Syringe Line
13 Nov 2024 //
PR NEWSWIRE
WuXi Biologics Earns AAA MSCI ESG Rating For Second Year
07 Nov 2024 //
PRESS RELEASE
WuXi Biologics Launches WuXia™ RidGS for Cell Line Development
28 Oct 2024 //
PR NEWSWIRE
WuXi Biologics Wins ESG Platinum Award Fourth Year In Row
16 Oct 2024 //
PRESS RELEASE
WuXi Biologics Included in Hang Seng ESG 50 Index
23 Sep 2024 //
PR NEWSWIRE
WuXi Completes First Scale-Up Of 2,000L WuXiUITM Bioprocess
30 Aug 2024 //
PRESS RELEASE
WuXi Biologics Reports Solid 2024 Interim Results
21 Aug 2024 //
PRESS RELEASE
Medigene And WuXi Biologics Enter Research Collaboration
08 Aug 2024 //
GLOBENEWSWIRE
WuXi Bio gains some traction in Europe in the face of Biosecure threat in the US
08 Aug 2024 //
ENDPTS
WuXi Biologics In S&P Sustainability Yearbook 2024 (China)
06 Aug 2024 //
PRESS RELEASE
WuXi shares jump after BIOSECURE`s exclusion from defense bill
12 Jun 2024 //
FIERCE PHARMA
AGC Biologics, BioConnection forge partnership to be an alternative to WuXi
22 May 2024 //
ENDPTS
New bill sets decoupling deadline for industry`s work with WuXi
10 May 2024 //
FIERCE PHARMA
WuXi Bio pulls out of 2024 BIO convention
01 May 2024 //
FIERCE PHARMA
WuXi Biologics 2023 ESG Report Shows Sustainability Commitment
29 Apr 2024 //
PR NEWSWIRE
Drug and biotech companies join lobbying push on China bill as scrutiny of WuXi
24 Apr 2024 //
ENDPTS
WuXi Biologics Reports Solid 2023 Annual Results
26 Mar 2024 //
PR NEWSWIRE
Hunting for ‘certainty and stability,’ WuXi Bio spotlights client relationships
26 Mar 2024 //
ENDPTS
Biotech trade association to split with China`s WuXi AppTec
14 Mar 2024 //
REUTERS
WuXi Biologics Achieves Leadership Level in 2023 CDP Climate Change Assessment
05 Mar 2024 //
PR NEWSWIRE
WuXi AppTec, Wuxi Biologics plunge to multi-year lows on fears over biotech bill
02 Feb 2024 //
REUTERS
WuXi Biologics Successfully Completes First 16,000L Manufacturing Run in Ireland
31 Jan 2024 //
PR NEWSWIRE
WuXi Biologics Launches WuXiaADCC PLUSâ„¢ For Enhanced Antibodies
25 Jan 2024 //
PRESS RELEASE
WuXi Biologics Launches WuXia ADCC PLUS™
24 Jan 2024 //
PR NEWSWIRE
BioNTech pays WuXi $20M for 2 preclinical monoclonal antibodies
11 Jan 2024 //
FIERCE BIOTECH
WuXi Biologics, WuXi AppTec plot expansions in US, China
08 Jan 2024 //
FIERCE PHARMA
WuXi Vaccines Wins Second Consecutive "Best Vaccine CMO Award" at AVEA 2023
12 Dec 2023 //
PR NEWSWIRE
WuXi Vaccines Passes First GMP Audit by a Global Vaccine Leader
06 Dec 2023 //
PR NEWSWIRE
WuXi Bio struggles amid CDMO industry downturn, stock plummets
04 Dec 2023 //
FIERCE PHARMA
